University of Pennsylvania School of Medicine Apr 15 2026 A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent. Findings on the new test, developed by a team from the Perelman School of Medicine at the University of Pennsylvania, are published today in Nature Medicine . What has been missing is a way to identify early disease activity before we see